BNTC
Benitec Biopharma Inc

6,337
Mkt Cap
$420.23M
Volume
118,292.00
52W High
$17.15
52W Low
$9.70
PE Ratio
-12.34
BNTC Fundamentals
Price
$11.65
Prev Close
$12.41
Open
$12.32
50D MA
$12.48
Beta
0.38
Avg. Volume
128,103.20
EPS (Annual)
-$1.05
P/B
3.48
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Benitec Biopharma Limited (NASDAQ:BNTC) Sees Large Increase in Short Interest
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totaling 1,963,460 shares, a...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
Benitec Biopharma (NASDAQ:BNTC) Director Buys $1,040,081.28 in Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L acquired 77,387 shares of the business's stock in a transaction that occurred on Monday, December...
MarketBeat·1mo ago
News Placeholder
Benitec Biopharma (NASDAQ:BNTC) Director Purchases $220,551.60 in Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L purchased 16,836 shares of the business's stock in a transaction on Friday, December 26th. The shares...
MarketBeat·1mo ago
News Placeholder
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Purchases 50,000 Shares of Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L purchased 50,000 shares of the stock in a transaction dated Tuesday, December 23rd. The shares were...
MarketBeat·1mo ago
News Placeholder
Suvretta Capital Management, L Purchases 77,387 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L acquired 77,387 shares of the business's stock in a transaction that occurred on Monday, December...
MarketBeat·1mo ago
News Placeholder
Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Benitec Biopharma (BNTC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·1mo ago
News Placeholder
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Purchases 10,215 Shares
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L bought 10,215 shares of the stock in a transaction dated Thursday, December 18th. The stock was...
MarketBeat·1mo ago
News Placeholder
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Acquires 16,384 Shares
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L purchased 16,384 shares of the company's stock in a transaction that occurred on Friday, December...
MarketBeat·1mo ago
News Placeholder
Suvretta Capital Management, L Acquires 10,215 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L acquired 10,215 shares of the stock in a transaction that occurred on Thursday, December 18th. The...
MarketBeat·1mo ago
News Placeholder
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Acquires 19,542 Shares of Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L bought 19,542 shares of the business's stock in a transaction that occurred on Monday, December 22nd...
MarketBeat·1mo ago
<
1
2
...
>

Latest BNTC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.